$URGN UroGen Pharma Ltd. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in UroGen Pharma Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in UroGen Pharma Ltd.. Insider overview, share value development, latest insider transactions and email notifications about new events in UroGen Pharma Ltd. for free.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: URGN
Company Address: 9 HA'TA'ASIYA ST RA'ANANA 4365007
UroGen Pharma Ltd. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 09 2021 | URGN | UroGen Pharma Ltd. | Cohen Fred E | Director | Option Exercise | A | 17.98 | 10,000 | 179,800 | 10,000 | |
| Jun 09 2021 | URGN | UroGen Pharma Ltd. | BUTITTA CYNTHIA M | Director | Option Exercise | A | 17.98 | 10,000 | 179,800 | 10,000 | |
| Jun 09 2021 | URGN | UroGen Pharma Ltd. | Holden Stuart | Director | Option Exercise | A | 17.98 | 10,000 | 179,800 | 10,000 | |
| May 04 2021 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | M | 0.00 | 500 | 0 | 3,500 | |
| May 04 2021 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Sell | S | 20.00 | 243 | 4,860 | 21,132 | 21.4 K to 21.1 K (-1.14 %) |
| May 04 2021 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Buy | M | 0.00 | 500 | 0 | 21,375 | 20.9 K to 21.4 K (+2.40 %) |
| Apr 22 2021 | URGN | UroGen Pharma Ltd. | Belldegrun Arie | Director | Option Exercise | M | 5.00 | 3,241 | 16,205 | 0 | |
| Apr 22 2021 | URGN | UroGen Pharma Ltd. | Belldegrun Arie | Director | Buy | M | 5.00 | 3,241 | 16,205 | 245,452 | 242.2 K to 245.5 K (+1.34 %) |
| Apr 22 2021 | URGN | UroGen Pharma Ltd. | Nussbaum Ran | Director | Option Exercise | M | 5.00 | 1,030 | 5,150 | 0 | |
| Apr 22 2021 | URGN | UroGen Pharma Ltd. | Nussbaum Ran | Director | Buy | M | 5.00 | 1,030 | 5,150 | 1,465,199 | 1.5 M to 1.5 M (+0.07 %) |
| Feb 02 2021 | URGN | UroGen Pharma Ltd. | Henderson Molly | Chief Financial Off ... | Option Exercise | A | 0.00 | 2,000 | 0 | 2,000 | |
| Feb 02 2021 | URGN | UroGen Pharma Ltd. | Henderson Molly | Chief Financial Off ... | Option Exercise | A | 22.07 | 6,000 | 132,420 | 6,000 | |
| Feb 02 2021 | URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
| Feb 02 2021 | URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | Option Exercise | A | 22.07 | 8,000 | 176,560 | 8,000 | |
| Feb 02 2021 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 |